← Back to Clinical Trials
Recruiting NCT06077942
FX Shoulder Solutions Retrospective / Prospective Clinical Study
Trial Parameters
Condition Rotator Cuff Syndrome of Shoulder and Allied Disorders
Sponsor FX Shoulder Solutions
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-12-06
Completion 2032-12-30
All Conditions
Interventions
FX Artificial Shoulder Prosthesis
Brief Summary
Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
Eligibility Criteria
Inclusion Criteria: * Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023. Exclusion Criteria: * Patient who does not meet the inclusion criteria above